Completed construction of the new vascular prosthesis plant
We are pleased to announce the completed construction of JUNKEN MEDICAL Ichihara Plant, a new plant for vascular prosthesis manufacturing.
JUNKEN MEDICAL’s J Graft series are the only domestic vascular prosthesis products manufactured in Japan. With its original shielding technology and special fiber structure, J Graft products are characterized by less postoperative fever, ease of use, an improved fit and better hemostasis.
J Graft products have been highly appreciated by medical facilities since their launch last April. Due to the limited production capacity of the existing plant, however, Japan Lifeline Co., Ltd. (the parent company of JUNKEN MEDICAL) has been unable to fulfill the large demand of the products.
The new plant will go into full-scale operation in February. This will ensure stable supply of J Graft products to the medical facilities, because the new plant will hold about three times the capacity of the existing one.
Based on the new plant, we will continue to develop and manufacture even better products that precisely and promptly reflect the needs of the medical front line.
Overview of the new plant
|